CPIX

Cumberland Pharmaceutical (CPIX)

Cumberland Pharmaceutical Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:CPIX

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/12/31	09 : 47	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CPIX	Cumberland Pharmaceutical Inc
2024/12/31	09 : 45	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CPIX	Cumberland Pharmaceutical Inc
2024/12/10	07 : 04	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CPIX	Cumberland Pharmaceutical Inc
2024/12/10	06 : 05	PR Newswire (US)	FDA APPROVES ACETADOTE® sNDA	NASDAQ:CPIX	Cumberland Pharmaceutical Inc
2024/12/06	07 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CPIX	Cumberland Pharmaceutical Inc
2024/12/06	07 : 04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CPIX	Cumberland Pharmaceutical Inc
2024/12/06	07 : 02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CPIX	Cumberland Pharmaceutical Inc
2024/11/09	07 : 04	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:CPIX	Cumberland Pharmaceutical Inc
2024/11/08	07 : 09	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CPIX	Cumberland Pharmaceutical Inc
2024/11/08	06 : 05	PR Newswire (US)	Cumberland Pharmaceuticals Reports Third Quarter 2024 Financial Results and Company Update	NASDAQ:CPIX	Cumberland Pharmaceutical Inc
2024/11/07	07 : 21	PR Newswire (US)	CUMBERLAND PHARMACEUTICALS RECEIVES FDA ORPHAN DRUG AND RARE PEDIATRIC DISEASE DESIGNATIONS FOR NEW TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY	NASDAQ:CPIX	Cumberland Pharmaceutical Inc
2024/11/07	07 : 12	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CPIX	Cumberland Pharmaceutical Inc
2024/11/06	06 : 40	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CPIX	Cumberland Pharmaceutical Inc
2024/11/06	06 : 39	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CPIX	Cumberland Pharmaceutical Inc
2024/11/06	06 : 38	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CPIX	Cumberland Pharmaceutical Inc
2024/11/06	06 : 05	PR Newswire (US)	New Study Compares Caldolor® (ibuprofen injection) to ketorolac	NASDAQ:CPIX	Cumberland Pharmaceutical Inc
2024/11/05	07 : 15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CPIX	Cumberland Pharmaceutical Inc
2024/11/01	05 : 05	PR Newswire (US)	CUMBERLAND PHARMACEUTICALS TO ANNOUNCE THIRD QUARTER 2024 FINANCIAL RESULTS	NASDAQ:CPIX	Cumberland Pharmaceutical Inc
2024/10/04	05 : 08	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CPIX	Cumberland Pharmaceutical Inc
2024/10/04	05 : 08	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CPIX	Cumberland Pharmaceutical Inc
2024/10/04	05 : 06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CPIX	Cumberland Pharmaceutical Inc
2024/09/06	00 : 31	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CPIX	Cumberland Pharmaceutical Inc
2024/09/05	23 : 42	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CPIX	Cumberland Pharmaceutical Inc
2024/09/05	07 : 29	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CPIX	Cumberland Pharmaceutical Inc
2024/09/05	06 : 42	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CPIX	Cumberland Pharmaceutical Inc
2024/08/10	06 : 03	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:CPIX	Cumberland Pharmaceutical Inc
2024/08/07	06 : 07	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:CPIX	Cumberland Pharmaceutical Inc
2024/08/07	05 : 05	PR Newswire (US)	Cumberland Pharmaceuticals Reports 16% Sequential Revenue Growth in Second Quarter 2024	NASDAQ:CPIX	Cumberland Pharmaceutical Inc
2024/08/03	06 : 16	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CPIX	Cumberland Pharmaceutical Inc
2024/08/03	06 : 15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:CPIX	Cumberland Pharmaceutical Inc